TYROSINE KINASE MUTATION

TYROSINE KINASE MUTATION was reported 25 times

TYROSINE KINASE MUTATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 BCL-2 Inhibitor [EPC] 6 0.0001
1 Kinase Inhibitor [EPC] 17 0.0000
2 Alkylating Drug [EPC] 4 0.0000
3 CD20-directed Cytolytic Antibody [EPC] 5 0.0000
4 Janus Kinase Inhibitor [EPC] 1 0.0000
5 Corticosteroid [EPC] 5 0.0000